Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2006-5-15
pubmed:abstractText
Despite evidence implicating insulin-like growth factor binding protein-3 (IGFBP-3) as a growth inhibitor of prostate cancer (CaP), little is known about changes in its regulation and function during progression to androgen independence.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0270-4137
pubmed:author
pubmed:copyrightInfo
Copyright 2006 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
971-86
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16541420-Androgens, pubmed-meshheading:16541420-Apoptosis, pubmed-meshheading:16541420-Cell Line, Tumor, pubmed-meshheading:16541420-Cell Lineage, pubmed-meshheading:16541420-Cell Survival, pubmed-meshheading:16541420-Disease Progression, pubmed-meshheading:16541420-Dose-Response Relationship, Drug, pubmed-meshheading:16541420-Doxycycline, pubmed-meshheading:16541420-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16541420-Humans, pubmed-meshheading:16541420-Insulin-Like Growth Factor Binding Protein 3, pubmed-meshheading:16541420-Male, pubmed-meshheading:16541420-Neoplasms, Hormone-Dependent, pubmed-meshheading:16541420-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:16541420-Prostatic Neoplasms, pubmed-meshheading:16541420-RNA, Messenger, pubmed-meshheading:16541420-Receptors, Androgen
pubmed:year
2006
pubmed:articleTitle
Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.
pubmed:affiliation
The Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural